Cargando…
The design and analysis of vaccine trials for COVID‐19 for the purpose of estimating efficacy
After a preliminary explanation as to how I came to know Andy Grieve and some remarks about his career and mine and how they have intersected, I consider the design and analysis of trials of vaccines for COVID‐19 for the purpose of estimating efficacy. Five large trials, run by the sponsors Pfizer/B...
Autor principal: | Senn, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350415/ https://www.ncbi.nlm.nih.gov/pubmed/35819115 http://dx.doi.org/10.1002/pst.2226 |
Ejemplares similares
-
Repurposing without purpose? Early innovation responses to the COVID‐19 crisis: Evidence from clinical trials
por: Hanisch, Marvin, et al.
Publicado: (2021) -
Mastering variation: variance components and personalised medicine
por: Senn, Stephen
Publicado: (2015) -
Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials
por: Kumar, Subodh, et al.
Publicado: (2022) -
Vaccine hesitancy in the post-vaccination COVID-19 era: a machine learning and statistical analysis driven study
por: Gupta, Himanshu, et al.
Publicado: (2022) -
Accelerated innovation through repurposing: exaptation of design and manufacturing in response to COVID‐19
por: Liu, Wei, et al.
Publicado: (2021)